Related Experiment Video
Updated: Jul 16, 2026
09:15
Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells
Published on: May 11, 2020
Tobacco use in relation to COPD and asthma
M N Hylkema1, P J Sterk, W I de Boer
1Dept of Pathology and Laboratory Medicine, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands. m.n.hylkema@path.umcg.nl
The European Respiratory Journal
|March 3, 2007
Summary
Smoking remains a leading global cause of preventable death, impacting smokers and those around them. This review discusses new concepts in smoking pathology, treatment, cessation, and control.
Area of Science:
- Public Health
- Respiratory Medicine
- Addiction Science
Background:
- Smoking is the foremost preventable cause of mortality globally.
- Millions continue to smoke, posing risks to personal and familial health.
- Smoking is a primary risk factor for chronic obstructive pulmonary disease (COPD) and complicates asthma management.
Purpose of the Study:
- To review current concepts in smoking-related pathology.
- To discuss advancements in the treatment of smoking-related conditions.
- To explore strategies for smoking cessation and comprehensive tobacco control.
Main Methods:
- Literature review of recent research on smoking.
- Synthesis of new concepts in pathology and treatment.
- Analysis of smoking cessation and tobacco control interventions.
Main Results:
- Smoking significantly impacts respiratory health, particularly COPD and asthma.
- Effective smoking cessation strategies are crucial for mitigating health risks.
- Integrated tobacco control measures are essential for public health.
Conclusions:
- Addressing smoking requires a multi-faceted approach encompassing pathology, treatment, cessation, and policy.
- Future research should focus on novel therapeutic targets and enhanced cessation support.
- Strengthened tobacco control policies are imperative to reduce the global burden of smoking-related diseases.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...